Scholars Central

Mini reviewPublished 28 Aug 2022

Propels in Developing CAR T-cell Therapy for HIV Cure

Authors: Antonio di Biagio

Journal of AIDS & Clinical Research

Volume 13 · Issue 8 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

AIDS (AIDS), which is brought about by HIV contamination, is a pestilence sickness that has killed great many individuals over the most recent a very long while. Despite the fact that blend antiretroviral treatment (CART) has empowered enormous advancement in smothering HIV replication, it neglects to kill HIV idly tainted cells and contaminated people remain HIV positive forever. Deep rooted antiretroviral treatment is expected to keep up with control of infection replication, which might bring about critical issues, including long haul harmfulness, significant expense, and shame. In this manner, novel remedial systems are direly expected to dispose of the viral repository in the host for HIV fix. In this survey, we look at a few potential methodologies with respect to HIV fix and spotlight on how we could use fanciful antigen receptor-changed T cells (CAR T) as a treatment to fix HIV contamination.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of AIDS & Clinical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of AIDS & Clinical Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Antonio di Biagio”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels